ImmunityBio

Monte Rosa Therapeutics

Revolution Medicines

Exelixis

Apollomics Inc - Ordinary Shares - Class A

Zymeworks Inc

Enliven Therapeutics Inc

Bristol-Myers

Arcellx

Mersana Therapeutics

Loncar Cancer Immunotherapy ETF

CNCR tracks an equal-weighted index of companies currently producing or in clinical trials for cancer immunotherapy drugs.

CNCR tracks an equal-weighted index of companies currently developing oncology drugs or selling cancer therapeutic products.

ARK Fintech Innovation ETF

Amplify Travel Tech ETF

VanEck Vectors Gaming ETF

iShares MSCI Brazil ETF

US Global Jets ETF

Industrial Select Sector SPDR Fund

The Covid-19 pandemic dinged a slew of asset classes, but these ETFs are positioned to benefit when the virus is squashed.

7 ETFs for the End of the Coronavirus

AstraZeneca

VanEck Vectors Biotech ETF

iShares Nasdaq Biotechnology ETF

SPDR S&P Biotech ETF

With the race to find a vaccine for the coronavirus, now drugmaker AstraZeneca is the latest to receive funding to generate a panacea.

AstraZeneca Joins Coronavirus Vaccine Race, Great For Biotech ETFs

Principal Healthcare Innovators Index ETF

iShares Genomics Immunology and Healthcare ETF

Shares of biotechnology company Moderna Inc (NASDAQ: MRNA) jumped 20% Monday on news that its mRNA-1273 coronavirus vaccine candidate is making positive progress.

3 ETFs For More Moderna Bets

U.S. stocks are continuing to soar higher on Monday, moving into positive territory for May, following news that drugmaker Moderna released positive, preliminary results from the first human trial of its experimental Covid-19 vaccine, generating optimism that the medical community was taking steps to beat the coronavirus. Shares of the biotech company soared surged over [.

Biotech ETFs Climbing As Moderna Builds Hope For Coronavirus Vaccine

Invesco Dynamic Biotechnology & Genome ETF

The rising incidence of cancer cases has encouraged several major pharmaceutical and biotech players to invest substantially in the developments of drugs.

Biotech ETFs to Gain From Latest Advancements in Cancer Drugs

First Trust NYSE Arca Biotechnology Index Fund

iShares U.S. Pharmaceuticals ETF

iShares U.S. Healthcare Providers ETF

Invesco DWA Healthcare Momentum ETF

ALPS Medical Breakthroughs ETF

SPDR S&P Health Care Services ETF

SPDR S&P Pharmaceuticals ETF

Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.

Healthcare & Biotech ETFs Digest GILD's Failure News: 5 Winners

ARK Genomic Revolution Multi-Sector ETF

Aytu BioScience

Co-Diagnostics

Forty Seven Inc

Vir Biotechnology

Growing coronavirus concerns provide some support to these biotech ETFs and stocks amid a massive market sell-off.

Coronavirus Scare Supports These Biotech ETFs & Stocks

Virtus LifeSci Biotech Clinical Trials ETF

ROBO Global Healthcare Technology and Innovation ETF

Can biotech ETFs repeat its success story of 2019 in the election year of 2020?

Will Biotech ETFs Excel in Election Year Post a Surge in 2019?

Global X Genomics & Biotechnology ETF

Following the new deals in the healthcare space, a few biotech ETFs hit new highs.

Biotech ETFs Hit New Highs on Deal Activities

Virtus LifeSci Biotech Products ETF

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to work in favor of the biotech market.

A Guide to Biotech ETF Investing

Ironwood Pharma

Jounce Therapeutics

Osmotica Pharmaceuticals Plc

Select Medical Holdings

Healthcare bounced back with an outperformance starting the fourth quarter.

Healthcare Sector Outperforming: 5 Best ETFs & Stocks QTD

Decent fundamentals and valuations as well as encouraging developments put these medical ETFs and stocks in focus.

Healthcare Drives Wall Street: 5 Soaring ETFs

Biotechnology company Amgen (NasdaqGS: AMGN) is throwing $2.7 billion into BeiGene (NasdaqGS: BGNE), sending the Chinese biotech’s shares surging and bolstering sector-related ETFs. Among the top performers on Friday, the Loncar Cancer Immunotheraphy ETF (NasdaqGM: CNCR) increased 3.2% and the VanEck Vectors Biotech ETF (BBH) advanced 2.7%.

News for Loncar Cancer Immunotherapy ETF ETF (CNCR)